Riskpilot← Back to searchSign inGet full accessWilson Health AB
ABIn liquidationOrg 5590361340Economic activity was not specified by tax authority · NACE 0000Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
+70% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -26K
+83% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -4K | +70% |
| Net profit | SEK -26K | +83% |
| Total assets | SEK 24K | -96% |
| Equity | SEK 24K | -90% |
| Employees | 0 | — |
Legal name
Wilson Health AB
Org number
5590361340
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
19 november 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva läkarverksamhet och företagshälsovård, äga och förvalta värdepapper samt annan därmed förenlig verkamhet.
Address
Email
avveckling@servando.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | −0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −15 | −33 | −18 | −12 | −4 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −15 | −33 | −18 | −12 | −4 |
| Net financials | −137 | −77 | −17 | 9 | −23 |
| Profit before tax | −75 | −110 | −298 | −158 | −26 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −75 | −110 | −298 | −158 | −26 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 373 | 1 087 | 865 | 666 | 24 |
| Equity | 1 373 | 1 079 | 594 | 240 | 24 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 8 | 271 | 426 | 0 |
| Total debt | — | 8 | 271 | 426 | — |
EBITDA margin
-376000.0%
This company
15.8%
Market median
-2379847% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-111.5%
This company
18.4%
Market median
-706% vs market
20202024
Net profit margin
-2636000.0%
This company
8.1%
Market median
-32543310% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JF Liquidator | Liquidator | 2026 |
| Former (1) | ||
GR Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Deputy Board Member | 2021 – 2025 | |
| Board of Directors | 2025 – 2026 | |
LC | Deputy Board Member | 2025 – 2026 |
| Board of Directors | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wilson Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Ståhl | Liquidator | 0 companies |
| Gisela René Gribe | Audit | 0 companies |
| Anna Maria Wilson | Deputy Board Member | 0 companies |
| Ann Madeleine Sundin | Board of Directors | 0 companies |
| Lu Chen | Deputy Board Member | 0 companies |
| Christopher Murray Wilson | Board of Directors | 0 companies |